Important Information for Public Relations Professionals
Below are the communications policies for New York Valves 2026, including how to handle embargoes and news releases, as well as suggested language for coverage of the event.
Media, investigators, organizations issuing press releases, and others with access to research accepted for presentation during New York Valves 2026 are required to abide by the embargo policies governing CRF® meetings.
The Cardiovascular Research Foundation® embargoes information presented as a late-breaking clinical trial, late-breaking clinical science, or featured clinical research. Coverage of these studies is strictly prohibited until the start time of each trial’s official presentation as listed in the New York Valves 2026 Program on the official New York Valves website. No journalist, exhibitor, or university (or affiliated organization or company) may disseminate information until the trial’s official presentation time. All embargo times are listed in Eastern Daylight Time (EDT). There is no official embargo for research presented as an abstract, challenging case, or during an innovation session. However, to maximize the impact of your presentation we recommend that no data be shared until the start of New York Valves and ideally not before your formal presentation.
Organizations presenting research at New York Valves 2026 may not engage in embargoed media outreach, conduct embargoed interviews, or share embargoed presentation materials without prior approval from the CRF® Press Office.
For questions regarding the embargo policy, please email [email protected].
Press releases announcing activities and/or research at New York Valves 2026 must adhere to the following guidelines:
- All news releases must comply with CRF®’s embargo policy.
- Releases must include a reference to New York Valves in the body, preferably in the first paragraph. Suggested language is provided below.
- Suggested language: “… presented at New York Valves 2026, the annual conference organized by the Cardiovascular Research Foundation® (CRF®)”
- All press releases referencing New York Valves 2026 and related events or presentations must receive approval from the CRF® Press Office prior to distribution. A copy or draft of the press release must be submitted in advance for review and approval. To obtain approval, please email the press release to the contact below. All submissions will be treated with strict confidentiality.
- Releases must not imply that CRF® endorses any product or service.
- Releases must not be scientifically misleading or ethically questionable.
CRF® Press Office Contact
Judy Romero
646.434.4608
[email protected]
These policies were last updated February 20, 2026 and are subject to change.
Please check with the CRF® Press Office for further updates.